Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | $3.55M | 13,649,384 | 0.00% | 100.00% | Net Buying | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $10.34M | 1,627,859 | 0.01% | 99.99% | Net Buying | |||
| XAIR | BEYOND AIR INC | $2.96M | 957,631 | 0.01% | 99.99% | Net Buying | Net Buying | ||
| LGVN | LONGEVERON INC | $7.94M | 3,188,197 | 0.02% | 99.98% | Net Selling | Net Selling | ||
| VVOS | VIVOS THERAPEUTICS INC | $3.28M | 20,118,023 | 0.00% | 46.82% | Net Buying | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $33.81M | 91,879,177 | 0.07% | 1.43% | ||||
| DVLT | DATAVAULT AI INC | $142.46M | 949,728,605 | 0.01% | 34.32% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $2.63M | 7,369,243 | 0.00% | 100.00% | Net Buying | |||
| ITRG | INTEGRA RESOURCES CORP | $564.30M | 202,257,000 | 0.03% | 0.00% | ||||
| IVVD | INVIVYD INC | $222.54M | 294,758,746 | 0.08% | 31.44% | Net Selling | Net Selling | ||
| EVTL | VERTICAL AEROSPACE LTD | $87.60M | 138,390,307 | 0.07% | 11.26% | Net Selling | Net Selling | ||
| TENX | TENAX THERAPEUTICS INC | $71.11M | 37,423,917 | 0.08% | 39.07% | Net Buying | Net Buying | ||
| GUTS | FRACTYL HEALTH INC | $95.51M | 159,179,848 | 0.04% | 18.42% | Net Buying | Net Buying | ||
| ELTX | ELICIO THERAPEUTICS INC | $49.67M | 26,281,882 | 0.01% | 43.40% | Net Buying | |||
| ACTU | ACTUATE THERAPEUTICS INC | $23.56M | 24,014,202 | 0.04% | 99.96% | Net Selling | Net Selling | ||
| KSCP | KNIGHTSCOPE INC | $26.92M | 23,618,357 | 0.01% | 42.01% | ||||
| ANVS | ANNOVIS BIO INC | $48.57M | 42,606,152 | 0.03% | 12.34% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $143.74M | 43,295,767 | 0.02% | 99.98% | ||||
| VERU | VERU INC | $41.09M | 17,050,320 | 0.01% | 99.99% | Net Buying | Net Buying | ||
| CRVO | CERVOMED INC | $36.74M | 15,119,096 | 0.00% | 100.00% | Net Buying | |||
| NMRA | NEUMORA THERAPEUTICS INC | $137.16M | 187,895,912 | 0.04% | 87.12% | Net Buying | Net Selling | ||
| GRI | GRI BIO INC | $4.22M | 2,186,115 | 0.00% | 100.00% | ||||
| BEAT | HEARTBEAM INC | $22.71M | 56,349,171 | 0.01% | 19.10% | Net Buying | |||
| ATOS | ATOSSA THERAPEUTICS INC | $22.15M | 9,979,298 | 0.01% | 99.99% | ||||
| HUMA | HUMACYTE INC | $162.79M | 277,798,105 | 0.03% | 11.08% | Net Buying | Net Buying | ||
| OCGN | OCUGEN INC | $359.46M | 339,110,401 | 0.04% | 10.35% | Net Selling | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $120.16M | 139,395,319 | 0.03% | 45.58% | Net Selling | Net Buying | ||
| OTLK | OUTLOOK THERAPEUTICS INC | $158.97M | 243,447,554 | 0.01% | 96.28% | Net Buying | Net Buying | ||
| INTZ | INTRUSION INC | $14.95M | 24,506,953 | 0.01% | 65.39% | Net Buying | Net Buying | ||
| LESL | LESLIE's INC | $3.89M | 9,365,475 | 0.00% | 100.00% | Net Selling | Net Selling | ||
| CMPX | COMPASS THERAPEUTICS INC | $342.17M | 180,087,915 | 0.09% | 22.93% | Net Buying | |||
| TARA | PROTARA THERAPEUTICS INC | $209.79M | 59,095,488 | 0.08% | 53.58% | Net Selling | Net Buying | ||
| SION | SIONNA THERAPEUTICS INC | $269.47M | 45,212,399 | 0.11% | 51.03% | Net Selling | Net Selling | ||
| OSTX | OS THERAPIES INC | $81.64M | 46,125,825 | 0.01% | 13.85% | ||||
| RNTX | REIN THERAPEUTICS INC | $69.01M | 86,267,032 | 0.05% | 41.65% | Net Buying | |||
| ENHA | ENHANCED GROUP INC | $558.45M | 387,810,095 | 0.00% | 82.79% | Net Buying | Net Buying | ||
| EYPT | EYEPOINT INC | $331.92M | 86,212,138 | 0.05% | 99.95% | Net Selling | Net Buying | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $114.04M | 124,497,980 | 0.04% | 10.86% | Net Selling | |||
| ADGM | ADAGIO MEDICAL HOLDINGS INC | $10.71M | 22,210,459 | 0.07% | 46.72% | Net Buying | |||
| CLNN | CLENE INC | $55.89M | 12,848,513 | 0.01% | 99.99% | Net Buying | Net Buying | ||
| ALGS | ALIGOS THERAPEUTICS INC | $65.44M | 12,489,116 | 0.01% | 99.99% | ||||
| CRBU | CARIBOU BIOSCIENCES INC | $139.37M | 107,207,513 | 0.05% | 8.03% | Net Selling | |||
| CABA | CABALETTA BIO INC | $432.34M | 169,545,445 | 0.09% | 2.57% | Net Buying | |||
| NGEN | NERVGEN PHARMA CORP | $218.15M | 106,412,633 | 0.01% | 0.00% | ||||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $260.49M | 252,907,464 | 0.05% | 60.39% | Net Selling | |||
| MRLN | MERLIN INC | $197.08M | 101,067,784 | 0.02% | 45.66% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.